September 15, 2022

Patients with heart failure typically experience high rates of morbidity and mortality, as well as increased healthcare costs. Disparities in risk factors and treatment strategies for patients with heart failure exist and need to be addressed by the healthcare community. Disparities in heart failure risk factors and treatment methods span across racial and ethnic groups....

Researchers investigated geographic disparities in heart failure outcomes in states with the highest and lowest life expectancies. Disparities in heart failure mortality and incidence, as well as the decline in survival rates of heart failure patients, emphasize the need for appropriate treatment strategies. Geographic disparities in life expectancy (LE) exist in the United States, which...

Patients with attention-deficit/hyperactivity disorder (ADHD) may be at higher risk of being overweight or obese. In addition, ADHD has been associated with type 2 diabetes and insulin resistance, which may contribute to the development of metabolic syndrome. Metabolic syndrome is one of the most common cardiovascular risk factors associated with high morbidity and mortality. Research...

Attention-deficit/hyperactivity disorder (ADHD) is closely associated with obsessive-compulsive disorder (OCD) in pediatric patients. ADHD comorbidity may have negative effects on treatment outcomes in patients with OCD. Attention-deficit/hyperactivity disorder (ADHD) is one of the most common psychiatric conditions that occur concomitantly with obsessive-compulsive disorder (OCD), and the rate of concomitant occurrence is up to 60%. Although...

Patients with transthyretin amyloidosis cardiomyopathy (ATTR-CM) are at risk of cardiovascular comorbidities, including atrial fibrillation and flutter. Routine ambulatory monitoring in patients with ATTR-CM could help drive the use of anticoagulation to prevent strokes. Heart complications, such as heart failure, are common in patients with transthyretin amyloidosis cardiomyopathy (ATTR-CM). Atrial fibrillation and flutter (AF/AFL), in...

The awareness and diagnosis of wild‐type transthyretin amyloid cardiomyopathy (ATTRwt CM) is challenging, despite ATTRwt being more common than previously thought. Screening is necessary for early detection and diagnosis of ATTRwt CM, as well as for timely treatment of the disease. The clinical characteristics of wild‐type transthyretin amyloid cardiomyopathy (ATTRwt CM) can vary among affected...

Heart failure, among other cardiovascular problems, is a typical manifestation of transthyretin amyloidosis cardiomyopathy (ATTR-CM). The prevalence of ATTR-CM as a phenotype of heart failure is often underestimated. Heart failure with preserved ejection fraction (HFpEF) affects more than half of patients with heart failure. The phenotypes of heart failure can vary, and treatment modalities are...